Cold Genesys Inc (Cold Genesys) is a pharmaceutical company that offers research, development and commercialization of drugs for the treatment of various cancer indications. The company offers products such as CG0070 a Phase-2a clinical trials stage candidate for the treatment of superficial bladder cancer and preclinical stage candidate CG0161 for the treatment of various breast, ovarian, lung, colon and prostate cancers. It develops its products based on its proprietary oncolytic virus technology. The company’s target therapy areas include Non-Muscle Invasive Bladder Cancer (MIBC), Non-Muscle Invasive Bladder Cancer (NMIBC) and other solid tumors. It operates with phase pivotal trials in patients with non-muscle invasive bladder cancer. Cold Genesys is headquartered in Santa Ana, California, the US.
Cold Genesys Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The Global Oncology Partnering 2014-2020: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Oncology partnering deals Financial deal terms for headline, upfront and royalty...
The Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2020: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right...
285 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Asthma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
290 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
The Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in vaccine and adjuvant partnering deals Deal...
287 pages •
By Global Industry Analysts
• Jun 2020
Amid the COVID-19 crisis and the looming economic recession, the Benzoic Acid market worldwide will grow by a projected US$307.7 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 3.8%. Benzoates, one of the segments analyzed and sized in this study, is forecast to grow at over 4.1% and reach...
The Global Artificial Intelligence Partnering Terms and Agreements 2014-2020 report provides an understanding and access to the artificial intelligence partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in artificial intelligence partnering deals Disclosed headlines, upfronts,...
KEY FINDINGS The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028. The major factors augmenting the global market growth are the growing number of road accidents and surgical procedures, increasing palliative care for patients going through intense suffering, and...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.